Examination of the immunogenicity of experimental polyvalent subunit vaccine against influenza viruses
Apstrakt
The immunogenicity of experimental polyvalent subunit vaccine against the influenza viruses, types A/H1N1, A1 /H3N2/ and B was studied in a biological assay on 15 experimental female rabbits, of the chin-chilla breed, weighing 700g, and 33 experimental mice, (BALB/C females), weighing 20 g. The experimental subunit vaccine was prepared from purified glycoprotein subunits isolated from outer envelopes of the influenza viruses, types A/Singapore/6/86 H1N1, A1/Peking/353189 H3N2 and B/Hamagota/45/90. Antigens were adsorbed on the adjuvant A1(OH)3, dissolved in 100 mmol/l of PBS. The finalconcentration of the adjuvant in the vaccine was 5 mg/ml. The haemagglutinating activity of isolated glycoprotein subunits in the vaccine was 128 HJ/0.1 ml. The samples of purified glycoprotein antigens, isolated from the above mentioned influenza viruses, with total protein concentrations of 0.20, 0.154 and 0.20 mg/ml, had significant haemagglutinating activities of 256 - 512 HJ/0.1 ml. The samples of no...ndisrupted and purified influenza virions (before the isolation of glycoprotein subunits), with higher total protein concentrations of 0.44. 0.30 and 0.53 mg/ml had haemagglutinating titres from 128 - 256 HJ/0.1 ml. One group of 10 experimental rabbits was immunized with 0.5 ml subunit vaccine (s/c per animal) and revaccinated with the same dose 24 days after the first vaccination. The mean geometric titres of HI antibodies (GMT) log 2/25 μl) against influenza viruses A/H1N1/, A1/H3N2/ and B in the sera of these experimental rabbits on day 7 after vaccination were 2.5; 2.0 and 2.5; on day 14: 3.5;3.0 and 3.0; on day 21: 4.0; 3.5 and 3.0; on day 28: 4.5; 4.0 and 3.5. In the blood sera of 5 control nonvaccinated rabbits, virusneutralizing HI antibodies were not detected. A group of 12 mice was immunized with 0.5 ml of the polyvalent influenza subunit vaccine (s/c per animal). The mean geometric titres of HI antibodies (GMT log 2/25 μl) against influenza viruses type A/H1/N1/, A1/H3/N2/ and B in the sera of immunized mice, on day 21 after vaccination were 4.6; 4.3 and 3.5. In the sera of 7 nonimmunized mice, virusneutralizing HI antibodies were no detected. Seven experimental mice were artificially infected 21 days after vaccination with a suspension (1 ml) of the above mentioned types of influenza viruses adapted to mice, with the titre EID 50 = 10-8.5 (for each type) intraperitoneally (i/p) and paranasally (p/n). An 7 vaccinated and artificially infected mice survived this infection without any symptoms. A second group of7 nonvaccinated control mice was artificially infected in the same way. All the animal were taken ill with acute respiratory infection 7 days later and 3 animale died on day 10 of the experiment.
Ključne reči:
influenza viruses / glycoprotein antigens / haemagglutinating activities / polyvalent subunit vaccine / immunization / artificial infection / rabbits / miceIzvor:
Acta Veterinaria-Beograd, 1997, 47, 5-6, 321-330Izdavač:
- Univerzitet u Beogradu - Fakultet veterinarske medicine, Beograd
Kolekcije
Institucija/grupa
Fakultet veterinarske medicineTY - JOUR AU - Milić, Nenad AU - Gađanski-Omerović, Gordana AU - Ašanin, Ružica PY - 1997 UR - https://vet-erinar.vet.bg.ac.rs/handle/123456789/77 AB - The immunogenicity of experimental polyvalent subunit vaccine against the influenza viruses, types A/H1N1, A1 /H3N2/ and B was studied in a biological assay on 15 experimental female rabbits, of the chin-chilla breed, weighing 700g, and 33 experimental mice, (BALB/C females), weighing 20 g. The experimental subunit vaccine was prepared from purified glycoprotein subunits isolated from outer envelopes of the influenza viruses, types A/Singapore/6/86 H1N1, A1/Peking/353189 H3N2 and B/Hamagota/45/90. Antigens were adsorbed on the adjuvant A1(OH)3, dissolved in 100 mmol/l of PBS. The finalconcentration of the adjuvant in the vaccine was 5 mg/ml. The haemagglutinating activity of isolated glycoprotein subunits in the vaccine was 128 HJ/0.1 ml. The samples of purified glycoprotein antigens, isolated from the above mentioned influenza viruses, with total protein concentrations of 0.20, 0.154 and 0.20 mg/ml, had significant haemagglutinating activities of 256 - 512 HJ/0.1 ml. The samples of nondisrupted and purified influenza virions (before the isolation of glycoprotein subunits), with higher total protein concentrations of 0.44. 0.30 and 0.53 mg/ml had haemagglutinating titres from 128 - 256 HJ/0.1 ml. One group of 10 experimental rabbits was immunized with 0.5 ml subunit vaccine (s/c per animal) and revaccinated with the same dose 24 days after the first vaccination. The mean geometric titres of HI antibodies (GMT) log 2/25 μl) against influenza viruses A/H1N1/, A1/H3N2/ and B in the sera of these experimental rabbits on day 7 after vaccination were 2.5; 2.0 and 2.5; on day 14: 3.5;3.0 and 3.0; on day 21: 4.0; 3.5 and 3.0; on day 28: 4.5; 4.0 and 3.5. In the blood sera of 5 control nonvaccinated rabbits, virusneutralizing HI antibodies were not detected. A group of 12 mice was immunized with 0.5 ml of the polyvalent influenza subunit vaccine (s/c per animal). The mean geometric titres of HI antibodies (GMT log 2/25 μl) against influenza viruses type A/H1/N1/, A1/H3/N2/ and B in the sera of immunized mice, on day 21 after vaccination were 4.6; 4.3 and 3.5. In the sera of 7 nonimmunized mice, virusneutralizing HI antibodies were no detected. Seven experimental mice were artificially infected 21 days after vaccination with a suspension (1 ml) of the above mentioned types of influenza viruses adapted to mice, with the titre EID 50 = 10-8.5 (for each type) intraperitoneally (i/p) and paranasally (p/n). An 7 vaccinated and artificially infected mice survived this infection without any symptoms. A second group of7 nonvaccinated control mice was artificially infected in the same way. All the animal were taken ill with acute respiratory infection 7 days later and 3 animale died on day 10 of the experiment. PB - Univerzitet u Beogradu - Fakultet veterinarske medicine, Beograd T2 - Acta Veterinaria-Beograd T1 - Examination of the immunogenicity of experimental polyvalent subunit vaccine against influenza viruses VL - 47 IS - 5-6 SP - 321 EP - 330 UR - https://hdl.handle.net/21.15107/rcub_veterinar_77 ER -
@article{ author = "Milić, Nenad and Gađanski-Omerović, Gordana and Ašanin, Ružica", year = "1997", abstract = "The immunogenicity of experimental polyvalent subunit vaccine against the influenza viruses, types A/H1N1, A1 /H3N2/ and B was studied in a biological assay on 15 experimental female rabbits, of the chin-chilla breed, weighing 700g, and 33 experimental mice, (BALB/C females), weighing 20 g. The experimental subunit vaccine was prepared from purified glycoprotein subunits isolated from outer envelopes of the influenza viruses, types A/Singapore/6/86 H1N1, A1/Peking/353189 H3N2 and B/Hamagota/45/90. Antigens were adsorbed on the adjuvant A1(OH)3, dissolved in 100 mmol/l of PBS. The finalconcentration of the adjuvant in the vaccine was 5 mg/ml. The haemagglutinating activity of isolated glycoprotein subunits in the vaccine was 128 HJ/0.1 ml. The samples of purified glycoprotein antigens, isolated from the above mentioned influenza viruses, with total protein concentrations of 0.20, 0.154 and 0.20 mg/ml, had significant haemagglutinating activities of 256 - 512 HJ/0.1 ml. The samples of nondisrupted and purified influenza virions (before the isolation of glycoprotein subunits), with higher total protein concentrations of 0.44. 0.30 and 0.53 mg/ml had haemagglutinating titres from 128 - 256 HJ/0.1 ml. One group of 10 experimental rabbits was immunized with 0.5 ml subunit vaccine (s/c per animal) and revaccinated with the same dose 24 days after the first vaccination. The mean geometric titres of HI antibodies (GMT) log 2/25 μl) against influenza viruses A/H1N1/, A1/H3N2/ and B in the sera of these experimental rabbits on day 7 after vaccination were 2.5; 2.0 and 2.5; on day 14: 3.5;3.0 and 3.0; on day 21: 4.0; 3.5 and 3.0; on day 28: 4.5; 4.0 and 3.5. In the blood sera of 5 control nonvaccinated rabbits, virusneutralizing HI antibodies were not detected. A group of 12 mice was immunized with 0.5 ml of the polyvalent influenza subunit vaccine (s/c per animal). The mean geometric titres of HI antibodies (GMT log 2/25 μl) against influenza viruses type A/H1/N1/, A1/H3/N2/ and B in the sera of immunized mice, on day 21 after vaccination were 4.6; 4.3 and 3.5. In the sera of 7 nonimmunized mice, virusneutralizing HI antibodies were no detected. Seven experimental mice were artificially infected 21 days after vaccination with a suspension (1 ml) of the above mentioned types of influenza viruses adapted to mice, with the titre EID 50 = 10-8.5 (for each type) intraperitoneally (i/p) and paranasally (p/n). An 7 vaccinated and artificially infected mice survived this infection without any symptoms. A second group of7 nonvaccinated control mice was artificially infected in the same way. All the animal were taken ill with acute respiratory infection 7 days later and 3 animale died on day 10 of the experiment.", publisher = "Univerzitet u Beogradu - Fakultet veterinarske medicine, Beograd", journal = "Acta Veterinaria-Beograd", title = "Examination of the immunogenicity of experimental polyvalent subunit vaccine against influenza viruses", volume = "47", number = "5-6", pages = "321-330", url = "https://hdl.handle.net/21.15107/rcub_veterinar_77" }
Milić, N., Gađanski-Omerović, G.,& Ašanin, R.. (1997). Examination of the immunogenicity of experimental polyvalent subunit vaccine against influenza viruses. in Acta Veterinaria-Beograd Univerzitet u Beogradu - Fakultet veterinarske medicine, Beograd., 47(5-6), 321-330. https://hdl.handle.net/21.15107/rcub_veterinar_77
Milić N, Gađanski-Omerović G, Ašanin R. Examination of the immunogenicity of experimental polyvalent subunit vaccine against influenza viruses. in Acta Veterinaria-Beograd. 1997;47(5-6):321-330. https://hdl.handle.net/21.15107/rcub_veterinar_77 .
Milić, Nenad, Gađanski-Omerović, Gordana, Ašanin, Ružica, "Examination of the immunogenicity of experimental polyvalent subunit vaccine against influenza viruses" in Acta Veterinaria-Beograd, 47, no. 5-6 (1997):321-330, https://hdl.handle.net/21.15107/rcub_veterinar_77 .